吃瓜不打烊

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • 吃瓜不打烊 Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • The Body Shops
    • Priced Out
    • Guns, Race, and Profit
    • Broken Rehab
    • Dead Zone
    • Denied
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Oct 4 2022

Full Issue

San Francisco Proposes Unapproved Treatment To Fight Opioid Addiction

Buprenorphine and methadone are approved by the FDA to treat addiction to some opioids, but San Francisco is proposing to study using hydromorphone as an alternative. Also: The first payments from a $518 million opioid settlement start to reach Washington.

San Francisco might study prescribing a little-known narcotic that鈥檚 not approved for treatment to people struggling with opioid addiction as part of its effort to stem the carnage from drug overdoses. The city already doles out doses of buprenorphine and methadone, two of three opioids approved by the U.S. Food and Drug Administration to treat addiction to other opioids, which have been shown to cut drug deaths by up to half. (Moench, 10/3)

The first payments from a $518 million settlement with the nation鈥檚 three largest opioid distributors will begin reaching Washington communities in December, providing much-needed cash officials can use to hire first responders or direct toward prevention, treatment and other services, Attorney General Bob Ferguson said Monday. (Johnson, 10/3)

The federal criminal trial of a former Eagle River nurse practitioner charged with supplying vast quantities of opioids that resulted in the overdose deaths of several of her patients started Monday in Anchorage. (Theriault Boots, 10/3)

The director of the Victoria and Albert Museum in London once told the BBC that the museum was 鈥減roud to have been supported by the Sacklers鈥 鈥 the family whose philanthropy is tied to the drug at the heart of the opioid crisis. The museum was 鈥渘ot going to be taking鈥 its name off the walls, the director, Tristram Hunt, added at a 2019 news conference. Yet now, the museum has done just that: removing signage that pointed visitors to its Sackler Courtyard, the glittering multimillion-dollar main entrance that opened to much fanfare in 2017, as well as to its Sackler Center for Arts Education. (Marshall, 10/3)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, August 3
  • Friday, July 31
  • Thursday, July 30
  • Wednesday, July 29
  • Tuesday, July 28
  • Monday, July 27
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • 吃瓜不打烊
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 KFF